Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 11, 359 (2005)
doi:10.1038/nm0405-359a
Tysabri withdrawal calls entire class into question
Emily Singer1
- Boston
Similar drugs may all pose a risk of infections, experts say.The future of a promising treatment for multiple sclerosis (MS) is in question after two patients takinag the drug were diagnosed with a rare neurological disorder.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
